GGrantIndex
← Search

PRODUCTION AND TESTING OF A MODIFIED VACCINIA ANKARA (MVA) VACCINE

$1,421,912N01FY2015AINIH

Sanofi Pasteur Biologics, Llc, Cambridge MA

Investigators

Abstract

The purpose of this contract is to support the advanced development and manufacture of a Modified Vaccinia Ankara (MVA) smallpox vaccine.

View original record on NIH RePORTER →